BridgeMD
New treatment option for Diplegic Cerebral Palsy With Spasticity
Official title Impact of rTMS Combined With Neurorehabilitation on Lower Extremity Motor Function and Spasticity in Children With Spastic Diplegic Cerebral Palsy
ClinicalTrials.gov ID: NCT07488429
What this study is testing
- What it's testing
- Cerebral palsy (CP) is widely recognized as the most prevalent cause of lifelong physical disability emerging in childhood across most global populations. While international data typically reports a prevalence ranging from 1.5 to 2.5 per 1,000 live births, in our specific national context, this rate is notably higher, reaching 4.4 per 1,000.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 18
You may be able to join if
- Diagnosis of Spastic Diplegic Cerebral Palsy.
- Between 5 and 18 years of age.
- Cooperative and oriented (capable of following commands).
- Gross Motor Function Classification System (GMFCS) Level II or III.
You likely can't join if
- Poor general health status.
- Children with severe comorbid conditions (e.g., total or partial blindness, severe lower extremity deformities, etc.).
- Diagnosis of epilepsy.
- History of seizures.
- Presence of a cardiac pacemaker.
- Presence of metal implants (specifically in the cranial and cervical regions).
See the full eligibility criteria
- Diagnosis of Spastic Diplegic Cerebral Palsy.
- Between 5 and 18 years of age.
- Cooperative and oriented (capable of following commands).
- Gross Motor Function Classification System (GMFCS) Level II or III.
- Poor general health status.
- Children with severe comorbid conditions (e.g., total or partial blindness, severe lower extremity deformities, etc.).
- Diagnosis of epilepsy.
- History of seizures.
- Presence of a cardiac pacemaker.
- Presence of metal implants (specifically in the cranial and cervical regions).
- Open wounds or infections at the application site.
- History of botulinum toxin injection or surgical intervention within the 6 months prior to study enrollment.
- History of Selective Posterior Rhizotomy (SPR) surgery.
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Turkey (Türkiye)
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.